Company / Operating Cash Flow per Share
Decoy Therapeutics Inc. Operating Cash Flow per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.64
FY2022
5-year range
-$5.64 / $2.05
FY2018-FY2022
Trend
-1201.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -1202% YoY in FY2022, a notable deviation from the 6-year average annual change of -229%.
Based on SEC 10-K filings.
-5.64 in FY2022.
Declined from $-2.57 to $-5.64 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 1201.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$5.64 | -1201.5% |
| FY2021 | -$0.43 | +83.1% |
| FY2020 | -$2.57 | -224.9% |
| FY2019 | $2.05 | +214.1% |
| FY2018 | -$1.80 | -45.6% |
| FY2017 | -$1.24 | -200.4% |
| FY2016 | -$0.41 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026